Stratified Reproduction
By Gina Maranto, Biopolitical Times guest contributor
| 08. 03. 2011
In a slim new volume, Outsourcing the Womb: Race, Class, and Gestational Surrogacy in a Global Market (Routledge, 2011), France Winddance Twine provides multiple accounts of the ways in which racism, classism, and colorism permeate the international market for wombs and gametes. For example, Twine cites the story of a Japanese woman who backs out of a surrogacy arrangement when she learns that the gestational mother, whom she had selected on the basis of her profile and skin color, is Korean. And there is the case of the black woman seeking IVF services who is "policed" in her choices by white doctors who insist it would be "inappropriate" for her to use "white" sperm if "black" sperm were available in the bank. Or the admission of the white, would-be surrogate who tells a researcher that she would carry "a Japanese baby or a Chinese baby because they are white to me," but says that "to give birth to a Black child would add one more controversial aspect to my life and I'm not ready to be on the front...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...